Myopia management has long been about slowing progression.
But what if we could go further?
With the introduction of HOYA MiYOSMART iQ spectacle lenses, that conversation is shifting in a meaningful and exciting way. Backed by compelling early clinical evidence, this next-generation innovation represents a significant step forward in how we care for children’s vision.
A Breakthrough in Clinical Performance
At just six months, children aged 4–12 wearing MiYOSMART iQ lenses showed no myopia progression on average, alongside minimal eye growth. Even more notably, clinical findings indicate that MiYOSMART iQ lenses are twice as effective as the original MiYOSMART lenses in controlling both axial elongation and myopia progression.
These results are groundbreaking and mark a turning point. For the first time, we are seeing outcomes that suggest we may not only slow myopia, but potentially hold it still.
Earlier Intervention, Greater Opportunity
One of the most important advancements with MiYOSMART iQ is its evaluation in younger children—as early as 4 years old. This opens the door to a more proactive, preventative approach to myopia care.
For families with a history of myopia, early intervention is key. MiYOSMART iQ can be introduced at the very first signs of myopia (as low as -0.25D)—and in some cases, even in children who are still plano but at high risk.
This shift toward earlier treatment represents a powerful opportunity: addressing myopia before it has the chance to meaningfully progress.
The Technology Behind the Advancement
MiYOSMART iQ builds on HOYA’s proven D.I.M.S. (Defocus Incorporated Multiple Segments) Technology, now enhanced with a Triple Enhanced Design (DIMS TED). This evolution introduces three key advancements:
A smaller central clear zone, bringing treatment zones closer to the visual axis
Increased defocus power, delivering a stronger signal to slow eye growth
An expanded treatment zone, ensuring consistent peripheral defocus across a wider field of vision—even in larger frames
Together, these refinements are designed to more consistently stimulate the near-peripheral retina, the area most responsive to myopia control signals.
Roberts and Brown Opticians is proud to be among a very select group of eyecare professionals with early access to MiYOSMART iQ lenses—well ahead of their wider release later this year.
This is more than just early adoption. It reflects a commitment to staying at the forefront of innovation and bringing the most advanced, evidence-based solutions directly to families in our care.
For parents navigating the challenges of childhood myopia, access to this level of technology now, before it becomes widely available, can make a meaningful difference, because early intervention is key.
Safe, Simple, and Designed for Real Life
While the science is impressive, the experience is seamless. MiYOSMART iQ lenses are also non-invasive, easy to adapt to, and supported by a strong safety profile, making them an ideal first-line option for myopia management.
Because the best myopia control solution is the one children will actually wear.
A Growing Need, A Stronger Solution
With childhood myopia rates rising globally, the need for effective intervention has never been greater. Since its launch in 2018, MiYOSMART has already helped millions of children worldwide. Now, with MiYOSMART iQ, that legacy continues—pushing the boundaries of what’s possible. This isn’t just an upgrade. It’s a shift in standard of care.
The Future Starts Now
MiYOSMART iQ represents over a decade of research, refinement, and commitment to children’s vision health. And now, it’s here at Roberts and Brown Opticians! We’re excited to bring this next chapter of myopia control to our community, early, thoughtfully, and with the experience fitting children that families trust.
If you’re exploring myopia management options for your child, we are here to help!
